A heated exchange on social media has erupted between a senior staffer for Florida Governor Ron DeSantis and the CEO of Trulieve Cannabis Corp, the state’s largest medical marijuana company, over the proposed cannabis legalization initiative, Amendment 3. The dispute centers around the amendment’s lack of provisions for home cultivation of cannabis, a feature DeSantis’ staffer criticizes as indicative of corporate greed, while the cannabis CEO argues it was excluded due to legal limitations.
Former President Donald Trump’s stance on Florida’s marijuana legalization initiative, Amendment 3, could be crucial to its success. While Trump hasn’t explicitly endorsed the measure, his recent comments suggest a shift in his views on marijuana criminalization. Trump ally Roger Stone believes a Trump endorsement would effectively guarantee victory for the amendment, highlighting the former president’s influence on the state’s political landscape.
In a historic shift, the US President’s administration has proposed reclassifying marijuana as a less dangerous drug. This would bring federal policy more in line with public opinion, where 88% of Americans support the legalization of marijuana for medical or recreational use. The reclassification from a Schedule I to a Schedule III drug would reduce the potential for arrests at the federal level, facilitate research, and provide a significant boost to the legal industry.
